Human chorionic gonadotrophin beta expression in malignant Barrett's oesophagus

Virchows Archiv

Volumn 445, Issue 3, 2004, Pages 279-284

  Couvelard, Anne ^a   Paraf, François ^b   Vidaud, Dominique ^c   Dubois, Sylvie ^a   Vidaud, Michel ^c   Fléjou, Jean François ^d   Degott, Claude ^a  

^a BEAUJON HOSPITAL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Barrett's adenocarcinoma; HCG ; Immunohistochemistry; Real time quantitative RT PCR; VEGF

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HCGBETA; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER INFILTRATION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CHORIONIC GONADOTROPHIN BETA GENE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERINEURIUM; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; VEGF GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4644292558     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1078-1     Document Type: Article

References (42)

1. Acevedo HF, Krichevsky A, Campbell-Acevedo EA, Galyon JC, Buffo MJ, Hartstsock RJ (1992) Expression of membrane associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells. Cancer 69:1829-1842
2. Acevedo HF, Tong JY, Hartsock RJ (1995) Human chorionic gonadotropin β subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 76:1306-1311
3. Bagshawe KD (1992) Choriocarcinoma: a model for tumor markers. Acta Oncol 31:99-106
4. Bellet D, Lazar V, Bieche I, Paradis V, Giovangrandi Y, Paterlini P, Lidereau R, Bedossa P, Bidart JM, Vidaud M (1997) Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells. Cancer Res 57:516-523
5. Bhalang K, Kafrawy AH, Miles DA (1999) Immunohistochemical study of the expression of human chorionic gonadotropin-beta in oral squamous cell carcinoma. Cancer 85:757-762
6. Bidart JM, Troalen F, Lazar V, Berger P, Marcillac I, Lhomme C, Droz JP, Bellet D (1992) Monoclonal antibodies to the free beta-subunit of human chorionic gonadotropin define three distinct antigenic domains and distinguish between intact and nicked molecules. Endocrinology 131:1832-1840
7. Bieche I, Lazar V, Nogues C, Poynard T, Giovangrandi Y, Bellet D, Lidereau R, Vidaud M (1998) Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma. Clin Cancer Res 4:671-676
8. Bonavina L, Via A, Incarbone R, Saino G, Peracchia A (2003) Results of surgical therapy in patients with Barrett's adenocarcinoma. World J Surgery 27:1062-1066
9. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727-4735
10. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26:86-91
11. Buckley CH, Fox H (1979) An immunohistochemical study of the significance of HCG secretion by large bowel adenocarcinoma. J Clin Pathol 32:368-372
12. Campo E, Palacin A, Benasco C, Quesada E, Cardesa (1987) A human chorionic gonadotropin in colorectal carcinoma. An immunohistochemical study. Cancer 59:1611-1616
13. Cossentino MJ, Wong RK (2003) Barrett's esophagus and risk of esophageal adenocarcinoma. Semin Gastrointest Dis 14:128-135
14. Couvelard A, Paraf F, Gratio V, Scoazec J-Y, Henin D, Degott C, Flejou J-F (2000) Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression. J Pathol 192:14-18
15. Dirnhofer S, Koessler P, Ensinger C, Feichtinger H, Madersbacher S, Berger P (1998) Production of trophoblastic hormones by transitional cell carcinoma of the bladder: association to tumor stage and grade. Hum Pathol 29:377-382
16. Giovangrandi Y, Parfait B, Asheur M, Olivi M, Lidereau R, Vidaud M, Bieche I (2001) Analysis of the human CGB/LHB gene cluster in breast tumors by real-time quantitative RT-PCR assays. Cancer Lett 168:93-100
17. Higashida T, Koizumi T, Yamagushi S, Ichimura T, Hasegawa K, Nishimura R (2001) Ovarian malignant mixed mesodermal tumor producing the free form of the beta-subunit of human chorionic gonadotropin. Int J Clin Oncol 6:97-100
18. Hotakainen K, Ljungberg B, Paju A, Rasmuson T, Alfthan H, Stenman UH (2002) The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. Br J Cancer 86:185-189
19. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S (1997) Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 79:206-213
20. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
21. Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G, Tahara E (1998) Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res 4:2195-2200
22. Koos RD (1995) Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol Reprod 52:1426-1435
23. Lauren P (1965) The two histological main types of gastric carcinoma diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31-49
24. Lazar V, Diez SG, Laurent A, Giovangrandi Y, Radvanyi F, Chopin D, Bidart JM, Bellet D, Vidaud M (1995) Expression of human chorionic gonadotropin beta subunit genes in superficial and invasive bladder carcinomas. Cancer Res 55:3735-3738
25. Luohimo J, Finne P, Alfthan H, Stenman UH, Haglund C (2002) Combination of HCGbeta, CA 1-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies. Anticancer Res 22:1759-1764
26. Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz JP, Lhomme C, Rougier P (1992) Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res. 52:3901-3907
27. Mason DY, Summons RE (1979) The labeled antigen method of immuno-peroxidase staining. J Histochem Cytochem 27:832-840
28. Melmed S, Braunstein GD (1983) Human chorionic gonadotropin stimulates proliferation of Nb 2 rat lymphoma cells J Clin Endocrinol Metab 56:1068-1070
29. Ming S-C (1977) Gastric carcinoma: a pathobiological classification. Cancer 39:2475-2485
30. Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, Ishigami S, Toda Y, Nakayama H, Fukumoto M, Fujita J, Imamura M (1996) Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 23:455-464
31. Neulen J, Raczek S, Pogorzelski M, Grunwald K, Yeo TK, Dvorak HF, Weich HA, Breckwoldt M (1998) Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol Hum Reprod 4:203-206
32. Niedergethmann M, Hildenbrand R, Wostbrock B, Hartel M, Sturm JW, Richter A, Post S (2002) High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas 25:122-129
33. Peto R, Pike MC, Armitage P (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39
34. Reynolds JC, Rahimi P, Hirschl D (2002) Barrett's esophagus: clinical characteristics. Gastroenterol Clin North Am 31:441-60
35. Rosenberg JC, Budev H, Edwards RC, Singal S, Steiger Z, Sundareson AS (1985) Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 55:1353-1360
36. Sheaff MT, Martin JE, Badenoch DF, Baithun SI (1996) beta hCG as a prognostic marker in adenocarcinoma of the prostate. J Clin Pathol 49:329-332
37. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964-3968
38. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM (1996) Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2:1679-1684
39. Taylor CM, Stevens H, Anthony FW, Wheeler T (1997) Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG, JAr and BeWo. Placenta 18:451-458
40. UICC (1987) TNM Classification of malignant tumors, 4th edition. Hermanek P, Sobin LH (eds) Springer, Berlin Heidelberg New York, pp 40-42
41. Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS, Soong YK (2002) Human chorionic gonadotropin-induced ovarian hyperstimulaion syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 87:3300-3308
42. Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O'Brien M, Bensted J (1995) The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erbB-2, beta HCG immunohistochemistry in advanced colorectal cancer. Ann Oncol 6:581-587